The identifier "SPBC18E5.14c" follows a pattern observed in Schizosaccharomyces pombe (fission yeast) gene nomenclature, where "SPBC" denotes a chromosomal locus. For example:
SPBC1773.16c: A fission yeast protein targeted by custom antibodies .
SPBC776.06c: Another fission yeast gene product with available antibodies .
Antibodies targeting Schizosaccharomyces pombe proteins are primarily used in basic research to study cell cycle regulation, DNA repair, and fungal biology. Examples include:
| Antibody Name | Target Protein | Application | Source |
|---|---|---|---|
| SPBC1773.16c Antibody | Hypothetical protein | Western blot, IF/ICC | Cusabio |
| SPBC776.06c Antibody | Uncharacterized protein | Immunoprecipitation | Cusabio |
These antibodies are typically produced as custom reagents for niche research needs . No functional or structural data exist for "SPBC18E5.14c" in this context.
Hypothetical or Obsolete Identifier: The identifier may refer to a deprecated or unannotated gene in fission yeast.
Typographical Error: Similar valid identifiers (e.g., SPBC18E5.14) exist but lack associated antibodies.
Proprietary or Unpublished Antibody: The antibody might be part of an undisclosed research project or commercial pipeline.
To address this gap, consider:
Re-validate the Identifier: Cross-check gene databases (e.g., PomBase) for "SPBC18E5.14c".
Custom Antibody Production: Platforms like Cusabio offer bespoke antibody services for uncharacterized targets .
Explore Structural Databases: SAbDab contains 1,624 antibody structures but no entries for this target .
If pursuing custom development:
KEGG: spo:SPBC18E5.14c
SPBC18E5.14c is an uncharacterized membrane protein found in Schizosaccharomyces pombe (strain 972/24843), commonly known as fission yeast. It is classified as a sequence orphan, meaning it lacks significant sequence homology with known characterized proteins . Antibodies against this protein are particularly valuable for studying membrane protein dynamics in S. pombe and potentially identifying novel functions within this model organism. The development of specific antibodies enables researchers to investigate protein localization, expression levels, and potential interaction partners, which are essential steps toward functional characterization of this understudied protein.
The primary validated applications for SPBC18E5.14c Antibody include ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot analysis . These techniques allow researchers to:
Detect and quantify SPBC18E5.14c protein in yeast lysates
Monitor expression levels under various experimental conditions
Verify protein size and potential post-translational modifications
Investigate protein-protein interactions through co-immunoprecipitation experiments
While not explicitly validated in the literature, researchers may also explore immunofluorescence microscopy applications to determine subcellular localization, following appropriate validation protocols.
Determining optimal antibody dilution requires systematic titration experiments for each application:
| Application | Recommended Starting Dilution Range | Optimization Approach |
|---|---|---|
| Western Blot | 1:500 - 1:2000 | Serial dilutions with constant antigen amount |
| ELISA | 1:1000 - 1:5000 | Checkerboard titration with varied antibody and antigen concentrations |
| Immunofluorescence | 1:100 - 1:500 | Start conservative, then reduce concentration if background is high |
For Western blots, researchers should prepare multiple identical membranes with the same samples and test different antibody dilutions to identify conditions that maximize specific signal while minimizing background. Include positive and negative controls to assess specificity at each dilution. Similar approaches using serial dilutions should be employed for ELISA applications, potentially using a competition binding format similar to the CBASQE approach described for other antibody systems .
For optimal Western blot results with SPBC18E5.14c Antibody:
Sample Preparation:
Harvest S. pombe cells in mid-log phase
Extract proteins using mechanical disruption in the presence of protease inhibitors
Solubilize membrane fractions using appropriate detergents (e.g., 1% NP-40 or 0.5% Triton X-100)
Electrophoresis and Transfer:
Separate proteins on 10-12% SDS-PAGE gels
Transfer to PVDF membranes (preferred for membrane proteins)
Verify transfer efficiency with reversible staining
Immunoblotting:
Block membranes with 5% non-fat milk in TBST for 1 hour at room temperature
Incubate with SPBC18E5.14c Antibody (1:1000 dilution) overnight at 4°C
Wash extensively with TBST (4 × 10 minutes)
Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour
Develop using enhanced chemiluminescence
Controls:
Include wild-type S. pombe lysates (positive control)
Include SPBC18E5.14c deletion strain lysates (negative control)
Use loading controls (e.g., anti-tubulin) to normalize expression levels
This protocol may require optimization based on specific laboratory conditions and equipment.
Thorough validation is essential before using SPBC18E5.14c Antibody in critical experiments:
Genetic Validation:
Compare signal between wild-type and SPBC18E5.14c knockout/knockdown strains
Perform rescue experiments with tagged SPBC18E5.14c constructs
Molecular Validation:
Conduct pre-adsorption tests by pre-incubating antibody with purified antigen
Verify signal reduction/elimination in pre-adsorption controls
Technical Validation:
Cross-Reactivity Assessment:
Test reactivity against related proteins or organisms
Analyze potential cross-reactivity through bioinformatic epitope prediction
Thorough validation data should be documented and included in publications to enhance reproducibility.
For rigorous immunoprecipitation experiments with SPBC18E5.14c Antibody:
| Control Type | Purpose | Implementation |
|---|---|---|
| Input Control | Verify presence of target protein before IP | Reserve 5-10% of lysate before immunoprecipitation |
| No-Antibody Control | Detect non-specific binding to beads | Perform IP procedure without adding SPBC18E5.14c Antibody |
| Isotype Control | Identify non-specific binding | Use non-relevant rabbit IgG at equivalent concentration |
| Negative Sample Control | Confirm specificity | Process SPBC18E5.14c knockout strain in parallel |
| Denaturing Control | Distinguish direct vs. indirect interactions | Compare results under native vs. denaturing conditions |
Additionally, researchers should consider reciprocal co-immunoprecipitation experiments and validation with differently tagged versions of the protein when studying protein-protein interactions.
Competition binding assays can provide valuable insights into antibody epitope specificity. Based on the CBASQE (CSP-based assay for serological quantification and equivalency) methodology described in the literature , researchers can develop a similar approach for SPBC18E5.14c:
Assay Development:
Generate a panel of peptides spanning different regions of SPBC18E5.14c
Label peptides with distinct reporter molecules
Establish baseline binding profiles for SPBC18E5.14c Antibody
Competition Format:
Pre-incubate SPBC18E5.14c Antibody with unlabeled competitors
Measure displacement of labeled peptides
Calculate IC50 values for different epitope regions
Data Analysis:
Convert IC50 values to absolute concentrations using standard curves
Compare binding profiles across different experimental conditions
Map epitope regions with highest competition efficiency
This approach would enable precise epitope mapping and could help identify functional domains within the SPBC18E5.14c protein.
For researchers interested in developing domain-specific antibodies:
Computational Analysis:
Perform sequence analysis to identify predicted domains
Use AlphaFold2 or similar tools to predict protein structure
Identify surface-exposed regions likely to be immunogenic
Peptide Design:
Generate peptides corresponding to specific domains
Ensure peptides are sufficiently long (15-25 amino acids) for immunogenicity
Consider coupling to carrier proteins for enhanced immune response
Screening Approaches:
Validation:
Confirm domain specificity using truncated protein constructs
Perform epitope mapping using peptide arrays
Validate functional implications through domain-specific inhibition studies
This approach would generate valuable reagents for dissecting SPBC18E5.14c function at the domain level.
Modern high-throughput approaches can significantly enhance antibody characterization:
Single-Cell Sequencing:
Epitope Binning:
Use surface plasmon resonance or bio-layer interferometry arrays
Determine epitope coverage across the protein
Identify non-competing antibody pairs for sandwich assays
Affinity Determination:
Employ high-throughput kinetic analysis
Quantify kon and koff rates for multiple antibody candidates
Select clones with optimal binding properties
Cross-Reactivity Profiling:
Screen against protein arrays containing related membrane proteins
Identify and eliminate cross-reactive antibodies
Generate specificity profiles for each candidate
These approaches would generate comprehensive characterization data to support advanced research applications.
| Issue | Potential Causes | Solutions |
|---|---|---|
| No signal | Insufficient protein, degradation, antibody dilution too high | Increase protein loading, add fresh protease inhibitors, optimize antibody concentration |
| Multiple bands | Cross-reactivity, protein degradation, post-translational modifications | Use knockout controls, optimize lysis conditions, validate with alternative methods |
| High background | Insufficient blocking, antibody concentration too high, inadequate washing | Extend blocking time, dilute antibody further, increase washing duration and volume |
| Inconsistent results | Antibody batch variation, protein extraction inconsistency | Use consistent antibody lots, standardize extraction protocol, implement internal controls |
For membrane proteins like SPBC18E5.14c, consider using specialized detergents (CHAPS, DDM) that better preserve membrane protein integrity and optimize sample heating conditions to prevent aggregation.
Cross-reactivity is a significant concern with antibodies against uncharacterized proteins:
Bioinformatic Analysis:
Perform BLAST searches to identify proteins with sequence similarity
Predict epitopes and cross-reference against other membrane proteins
Generate a list of potential cross-reactive proteins for experimental validation
Experimental Validation:
Test antibody against purified potential cross-reactive proteins
Overexpress candidate cross-reactive proteins and assess signal increase
Deplete or knockout potential cross-reactive proteins and assess signal change
Epitope Refinement:
Develop competition assays with specific peptides to block cross-reactive binding
Generate new antibodies against unique regions if cross-reactivity is confirmed
Consider using monoclonal alternatives if polyclonal exhibits excessive cross-reactivity
Documentation:
Explicitly document known cross-reactivity in experimental methods
Implement appropriate controls to distinguish specific from non-specific signals
Consider multiple antibody approach for critical findings
These strategies ensure experimental rigor when working with antibodies against uncharacterized proteins.
SPBC18E5.14c Antibody can facilitate several research approaches:
Localization Studies:
Determine subcellular distribution under different conditions
Track localization changes during cell cycle or stress
Identify potential functional compartmentalization
Protein Interactions:
Identify binding partners through immunoprecipitation followed by mass spectrometry
Validate interactions through reciprocal co-immunoprecipitation
Map interaction domains through deletion constructs
Expression Regulation:
Monitor protein levels under various physiological conditions
Correlate protein expression with transcriptional changes
Investigate post-translational regulation mechanisms
Functional Characterization:
Combine with genetic approaches (knockout/knockdown)
Test phenotypic consequences of blocking specific domains with the antibody
Develop functional assays based on localization and interaction data
These approaches would significantly advance understanding of this uncharacterized protein's role in yeast biology.
Several cutting-edge technologies offer promising applications:
Proximity Labeling:
Convert SPBC18E5.14c Antibody to a BioID or APEX2 conjugate
Map proximal proteins in the native cellular environment
Identify transient or weak interactions not captured by traditional methods
Super-Resolution Microscopy:
Employ techniques like STORM or PALM with fluorophore-conjugated antibodies
Achieve nanometer-scale resolution of protein localization
Visualize membrane microdomains containing SPBC18E5.14c
Cryo-Electron Tomography:
Use antibody labeling to identify SPBC18E5.14c in cellular tomograms
Visualize native membrane context at molecular resolution
Integrate with structural prediction methods like AlphaFold2
Single-Molecule Tracking:
Conjugate quantum dots or photoswitchable fluorophores to Fab fragments
Track single SPBC18E5.14c molecules in living cells
Determine diffusion properties and confinement zones
These technologies could provide unprecedented insights into SPBC18E5.14c function and dynamics.